Predictive Biosciences Inc.

Industry

  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
See more in Biomedtracker

Latest on Predictive Biosciences Inc.

Medtech Insight

Molecular Dx Labs’ Concerns Shift To Coverage Issues With Release Of Interim Medicare Payment Amounts

Labs that run molecular diagnostic tests are not only worried about getting short-changed on payment for the tests by some Medicare Part B contractors, but that the tests will not be covered at all. “

Medtech Insight

Molecular Dx Labs Fret Over Medicare Payment Setting, Or, In Some Cases, Lack Thereof

Laboratories that run molecular diagnostic tests are increasingly alarmed at what they describe as a lack of transparency in Medicare price setting and, in some cases, failure by Medicare contractors

Scrip

On The Move: Who’s Going Where In Biopharma And Medtech Start-Ups

 
• By Regina Paleski

Start-Up Execs Blueprint Medicines Corp. Christoph Lengauer, PhD To:CSO (January) From:VP, Global Head, Oncology Drug Discovery & Preclinical Dev., Sanofi Tel:617-585-2033 Cerulean Pharma Inc.

Scrip

Start-Up Quarterly Statistics, Q4 2010

 
• By Deanna Kamienski

Biopharmaceutical, medical device, and in vitro diagnostics start-up dealmaking from October through December 2010. Data from Elsevier's Strategic Transactions. Deanna F. Kamienski Financings In the f